A, B., RL, F., A, M., JB, H., AM, B., AR, P., . . . CG, S. (2012). Indomethacin-loaded lipid-core nanocapsules reduce the damage triggered by Aβ1-42 in Alzheimer's disease models. International journal of nanomedicine, 7, 4927. https://doi.org/10.2147/IJN.S35333
Chicago Style (17th ed.) CitationA, Bernardi, Frozza RL, Meneghetti A, Hoppe JB, Battastini AM, Pohlmann AR, Guterres SS, and Salbego CG. "Indomethacin-loaded Lipid-core Nanocapsules Reduce the Damage Triggered by Aβ1-42 in Alzheimer's Disease Models." International Journal of Nanomedicine 7 (2012): 4927. https://doi.org/10.2147/IJN.S35333.
MLA (9th ed.) CitationA, Bernardi, et al. "Indomethacin-loaded Lipid-core Nanocapsules Reduce the Damage Triggered by Aβ1-42 in Alzheimer's Disease Models." International Journal of Nanomedicine, vol. 7, 2012, p. 4927, https://doi.org/10.2147/IJN.S35333.